Understand the source comparison
DSIP and Epithalon Stacking: Research Design Comparison
Primary Biological Target Delta-wave sleep, HPA axis stress regulation, corticotropin suppression Telomerase activation, telomere elongation, pineal melatonin restoration Dual targeting: sleep architecture + cellular senescence pathways Combined protocol addre
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Primary Biological Target
- Delta-wave sleep, HPA axis stress regulation, corticotropin suppression
- Telomerase activation, telomere elongation, pineal melatonin restoration
- Dual targeting: sleep architecture + cellular senescence pathways
- Combined protocol addresses aging mechanisms DSIP or Epithalon alone cannot—neurological recovery and chromosomal stability require distinct interventions
- Standard Dose Range
- 100–500mcg per dose, 2–3× weekly
- 5–10mg daily for 10–20 days per cycle
- DSIP 250–350mcg evening + Epithalon 10mg morning for 10 days
- Stacking does not require dose reduction of either compound—pathways do not compete or saturate shared clearance mechanisms
- Administration Timing
- 30–60 min before sleep onset (9–11 PM typical)
- Morning administration (6–10 AM) to align with circadian pineal function
- Temporal separation prevents injection site overlap and respects circadian alignment of each peptide
- Proper timing is non-negotiable—evening Epithalon disrupts melatonin onset, morning DSIP wastes its sleep-induction window
- Cycle Length
- Continuous or intermittent use (no fixed cycle required)
- 10-day cycle repeated every 4–6 months
- Epithalon 10-day cycle with DSIP dosed 3× weekly throughout
- DSIP can run continuously through Epithalon cycles—no washout period required between compounds
- Measurable Endpoints
- Sleep latency, slow-wave sleep %, cortisol awakening response
- Telomere length (qPCR), telomerase activity assay, serum melatonin
- Combined metrics: sleep quality (polysomnography) + cellular aging markers (telomere assays)
- Stacking allows multi-dimensional assessment—sleep architecture improvements appear within 7–10 days, telomere effects require 60–90 days post-cycle